Drug Database
Back to search

United States· US:45802-042_ab0a6fe2-5ee0-408c-9e1d-30ce29344d16

Clindesse

A clindamycin product containing clindamycin phosphate, registered in United States by Padagis Israel Pharmaceuticals Ltd. The same ATC class is registered in 14 of our 19 countries.

ATC G01AA10US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedClindesseATCG01AA10REGISTER NO.US:45802-042_ab0a6fe2…PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about clindamycin phosphateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Clindamycin is registered in 14 of 19 countries.

Countries holding a registration under ATC G01AA10 (clindamycin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose
Search clindamycin products by name

Clindamycin · ATC G01AA10

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of clindamycin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • United States: $0.063 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Clindamycin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • US United States$0.063 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CLINDAMYCIN PHOSPHATE
Manufacturer
Padagis Israel Pharmaceuticals Ltd
Country
United States (US)
ATC code
G01AA10
ATC class
Clindamycin
Defined daily dose
0.1 g, V
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    4580204201
    1 APPLICATOR in 1 CARTON (45802-042-01) / 5 g in 1 APPLICATOR
  • ndc11
    4580204202
    1 APPLICATOR in 1 CARTON (45802-042-02) / 5 g in 1 APPLICATOR
  • ndc11
    45802-042-01
  • ndc11
    45802-042-02

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for clindamycin.

Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check clindamycin against other medicinesHow interaction checks work

Clindamycin · interactions on record

10 records

  • 10 moderate

Most severe, free to view

  • TubocurarineM03AA02moderate
  • SuxamethoniumM03AB01moderate
  • PancuroniumM03AC01moderate
  • VecuroniumM03AC03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Clindamycin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clindamycin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Clindac, Clindamycin 1a Pharma
  • Belgium · Clindamycin Noridem, Clindamycin Sandoz
  • Bulgaria · Clindamycin Kabi, Далацин C
  • Cyprus · Arfarel, Clindamycin Abr
  • Czechia · Clindamycin Hameln, Clindamycin Kabi
  • Germany · Clinda-Ipp, Clinda-Saar
  • Denmark · Clindamycin Abcur, Clindamycin Alternova
  • Estonia · Clindamycin Mip, Dalacin
  • Spain · Clindamicina Aristo, Clindamicina Kalceks
  • Finland · Clindamycin Abcur, Clindamycin Fresenius Kabi
  • France · Clindamycine Kabi, Clindamycine Kalceks
  • United Kingdom (Northern Ireland) · Clindamycin, Clindamycin As Kalceks
  • Greece · Cleo-Fort, Clidacin 1% Διάλυμα Εξωτερικήσ Χρήσησ
  • Croatia · Aknet, Dalacin
  • Hungary · Clindamycin Anfarm, Clindamycin Hameln
  • Ireland · Clindamycin, Clindamycin Kalceks
  • Iceland · Clindamycin Abcur, Clindamycin Eql Pharma
  • Italy · Cleocin, Clindamicina Fosfato Bioindustria L.I.M.
  • Lithuania · Clindamycin Mip, Dalacin C
  • Luxembourg · Clindamycine Eg, Clindamycine Fresenius Kabi
  • Latvia · Clindamycin Kalceks, Clindamycin Mip
  • Malta · Clidacin Ba Free Amp, Clindamicina Accord
  • Netherlands · Clindamycin Teva, Clindamycine Added Pharma
  • Norway · Clindamycin Abcur, Clindamycin Kalceks
  • Poland · Clindacne, Clindalin
  • Portugal · Clincina, Clindamicina Generis
  • Romania · Clindamicină Hameln, Clindamycin Mip
  • Sweden · Clindamycin Abcur, Clindamycin Actavis
  • Slovenia · Dalacin, Klimicin
  • Slovakia · Clindamycin Hameln, Clindamycin Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0db94c46-0bc8-471a-8083-d45c77c3f5ab
GET /v1/drugs/0db94c46-0bc8-471a-8083-d45c77c3f5ab?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "VAGINAL",
  "source": "ndc",
  "strength": "100",
  "substance": "CLINDAMYCIN PHOSPHATE",
  "productndc": "45802-042",
  "dosage_form": "CREAM",
  "dea_schedule": null,
  "strength_unit": "mg/5g",
  "application_number": "NDA050793",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about clindamycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console